CpG-B ODNs potently induce low levels of IFN-αβ and induce IFN-αβ-dependent MHC-I cross-presentation in DCs as effectively as CpG-A and CpG-C ODNs

Journal of Leukocyte Biology

Volumn 81, Issue 4, 2007, Pages 1075-1085

  Gray, Reginald C ^a,b   Kuchtey, John ^a,c   Harding, Clifford V ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antigen presentation; CpG oligodeoxynucleotides; Dendritic cells; Toll like receptor 9; Type I interferon

Indexed keywords

ALPHA2B INTERFERON; CPG OLIGODEOXYNUCLEOTIDE; CPG OLIGODEOXYNUCLEOTIDE A; CPG OLIGODEOXYNUCLEOTIDE B; CPG OLIGODEOXYNUCLEOTIDE C; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BONE MARROW CELL; CROSS PRESENTATION; DENDRITIC CELL; DRUG EFFICACY; DRUG MECHANISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGEN PRESENTATION; CELLS, CULTURED; CPG ISLANDS; CROSS-PRIMING; DENDRITIC CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; INTERFERON-ALPHA; MICE; MICE, INBRED C57BL; MICE, INBRED CBA; OLIGODEOXYRIBONUCLEOTIDES; RECEPTOR, INTERFERON ALPHA-BETA; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 33947682216     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1006606     Document Type: Article

References (28)

1. Wagner, H. (2004) The immunobiology of the TLR9 subfamily. Trends Immunol. 25, 381-386.
2. Klinman, D. M. (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 4, 249-258.
3. Krieg, A. M. (2002) CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 20, 709-760.
4. Vollmer, J., Weeratna, R., Payette, P., Jurk, M., Schetter, C., Laucht, M., Wader, T., Tluk, S., Liu, M., Davis, H. L., Krieg, A. M. (2004) Characterization of three CpG oligodeoxynucleotide classes with distinct immunostimulatory activities. Eur. J. Immunol. 34, 251-262.
5. Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S., Endres, S. (2003) Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-α induction in plasmacytoid dendritic cells. Eur. J. Immunol. 33, 1633-1641.
6. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., Akira, S. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408, 740-745.
7. Takeda, K., Kaisho, T., Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376.
8. Krug, A., Rothenfusser, S., Hornung, V., Jahrsdorfer, B., Blackwell, S., Ballas, Z. K., Endres, S., Krieg, A. M., Hartmann, G. (2001) Identification of CpG oligonucleotide sequences with high induction of IFN-α/β in plasmacytoid dendritic cells. Eur. J. Immunol. 31, 2154-2163.
9. Hemmi, H., Kaisho, T., Takeda, K., Akira, S. (2003) The roles of Toll-like receptor 9, MyD88, and DNA-dependent protein kinase catalytic subunit in the effects of two distinct CpG DNAs on dendritic cell subsets. J. Immunol. 170, 3059-3064.
10. Harding, C. V. (1995) Phagocytic processing of antigens for presentation by MHC molecules. Trends Cell Biol. 5, 105-109.
11. Jondal, M., Schirmbeck, R., Reimann, J. (1996) MHC class I-restricted CTL responses to exogenous antigens. Immunity 5, 295-302.
12. Ackerman, A. L., Cresswell, P. (2004) Cellular mechanisms governing cross-presentation of exogenous antigens. Nat. Immunol. 5, 678-684.
13. Bevan, M. J. (1976) Cross-priming for a secondary response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay. J. Exp. Med. 143, 1283-1288.
14. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G. (2002) Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
15. Askew, D., Chu, R. S., Krieg, A. M., Harding, C. V. (2000) CpG DNA induces maturation of dendritic cells with distinct effects on nascent and recycling MHC-II antigen processing mechanisms. J. Immunol. 165, 6889-6895.
16. Sparwasser, T., Koch, E. S., Vabulas, R. M., Heeg, K., Lipford, G. B., Ellwart, J. W., Wagner, H. (1998) Bacterial DNA and immunostimulatory CpG oligonucleotides trigger maturation and activation of murine dendritic cells. Eur. J. Immunol. 28, 2045-2054.
17. Hartmann, G., Weiner, G. J., Krieg, A. M. (1999) CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells. Proc. Natl. Acad. Sci. USA 96, 9305-9310.
18. Jakob, T., Walker, P. S., Krieg, A. M., Udey, M. C., Vogel, J. C. (1998) Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA. J. Immunol. 161, 3042-3049.
19. Cho, H. J., Hayashi, T., Datta, S. K., Takabayashi, K., Van Uden, J. H., Horner, A., Corr, M., Raz, E. (2002) IFN-α β promote priming of antigen-specific CD8+ and CD4+ T lymphocytes by immunostimulatory DNA-based vaccines. J. Immunol. 168, 4907-4913.
20. Kuchtey, J., Chefalo, P. J., Gray, R. C., Ramachandra, L., Harding, C. V. (2005) Enhancement of dendritic cell antigen cross-presentation by CpG DNA involves type I IFN and stabilization of class I MHC mRNA. J. Immunol. 175, 2244-2251.
21. Van Uden, J. H., Tran, C. H., Carson, D. A., Raz, E. (2001) Type I interferon is required to mount an adaptive response to immunostimulatory DNA. Eur. J. Immunol. 31, 3281-3290.
22. Vicari, A. P., Chiodoni, C., Vaure, C., Ait-Yahia, S., Dercamp, C., Matsos, F., Reynard, O., Taverne, C., Merle, P., Colombo, M. P., O'Garra, A., Trinchieri, G., Caux, C. (2002) Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J. Exp. Med. 196, 541-549.
23. Jurk, M., Schulte, B., Kritzler, A., Noll, B., Uhlmann, E., Wader, T., Schetter, C., Krieg, A. M., Vollmer, J. (2004) C-Class CpG ODN: sequence requirements and characterization of immunostimulatory activities on mRNA level. Immunobiology 209, 141-154.
24. Tobian, A. A., Potter, N. S., Ramachandra, L., Pai, R. K., Convery, M., Boom, W. H., Harding, C. V. (2003) Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide. J. Immunol. 171, 1413-1422.
25. Brawand, P., Fitzpatrick, D. R., Greenfield, B. W., Brasel, K., Maliszewski, C. R., De Smedt, T. (2002) Murine plasmacytoid pre-dendritic cells generated from Flt3 ligand-supplemented bone marrow cultures are immature APCs. J. Immunol. 169, 6711-6719.
26. Pfeifer, J. D., Wick, M. J., Roberts, R. L., Findlay, K. F., Normark, S. J., Harding, C. V. (1993) Phagocytic processing of bacterial antigens for class I MHC presentation to T cells. Nature 361, 359-362.
27. Pai, R. K., Pennini, M. E., Tobian, A. A., Canaday, D. H., Boom, W. H., Harding, C. V. (2004) Prolonged Toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits γ interferon-induced regulation of selected genes in macrophages. Infect. Immun. 72, 6603-6614.
28. Muller, U., Steinhoff, U., Reis, L. F., Hemmi, S., Pavlovic, J., Zinkernagel, R. M., Aguet, M. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.